Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

September 1976

Volume 277 International Conference on Immunotherapy of Cancer

Pages iii–iii, 1–741

    1. DEDICATION (page iii)

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41686.x

    2. HISTORY AND PROSPECTS OF IMMUNOTHERAPY OF CANCER: AN INTRODUCTION (pages 1–6)

      Chester M. Southam

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41687.x

  1. PART I. REPAIR AND REPLACEMENT OF INADEQUATE IMMUNE MECHANISMS

    1. Top of page
    2. PART I. REPAIR AND REPLACEMENT OF INADEQUATE IMMUNE MECHANISMS
    3. PART II. NONSPECIFIC IMMUNOSTIMULATION AS THERAPY FOR CANCER
    4. PART III. SPECIFIC ACTIVE IMMUNOTHERAPY (TUMOR VACCINES) FOR CANCER
    5. PART IV. SPECIFIC ADOPTIVE IMMUNOTBERAPY FOR CANCER
    6. PART V. INSTRUCTIONAL METHODS OF IMMUNOTHERAPY
    7. PART VI. SPECISC IMMUNOTHERAPY (ANTIBODIES) FOR TREATMENT OF CANCER
    8. PART VII. CONFERENCE SUMMATION AND CRITIQUE
    1. ADOPTIVE IMMUNOTHERAPY UTILIZING THORACIC DUCT LYMPHOCYTES (pages 7–19)

      Robert H. Yonemoto

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41688.x

  2. PART II. NONSPECIFIC IMMUNOSTIMULATION AS THERAPY FOR CANCER

    1. Top of page
    2. PART I. REPAIR AND REPLACEMENT OF INADEQUATE IMMUNE MECHANISMS
    3. PART II. NONSPECIFIC IMMUNOSTIMULATION AS THERAPY FOR CANCER
    4. PART III. SPECIFIC ACTIVE IMMUNOTHERAPY (TUMOR VACCINES) FOR CANCER
    5. PART IV. SPECIFIC ADOPTIVE IMMUNOTBERAPY FOR CANCER
    6. PART V. INSTRUCTIONAL METHODS OF IMMUNOTHERAPY
    7. PART VI. SPECISC IMMUNOTHERAPY (ANTIBODIES) FOR TREATMENT OF CANCER
    8. PART VII. CONFERENCE SUMMATION AND CRITIQUE
    1. RECOGNITION FACTORS AND NONSPECIFIC MACROPHAGE ACTIVATION IN THE TREATMENT OF NEOPLASTIC DISEASE (pages 20–44)

      Peter W. A. Mansell, Nicholas R. DiLuzio, Rose McNamee, Geoffrey Rowden and Julian W. Proctor

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41689.x

    2. MARROW TRANSPLANTATION FOR ACUTE LEUKEMIA IN MAN (pages 52–59)

      A. Fefer, E. D. Thomas, C. D. Buckner, M. A. Cheever, R. A. Clift, A. B. Einstein Jr., P. E. Neiman, R. Storb and P. L. Weiden

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41691.x

    3. CRITICAL REVIEW OF PREVIOUSLY REPORTED ANIMAL STUDIES OF TUMOR IMMUNOTHERAPY WITH NON-SPECIFIC IMMUNOSTIMULANTS (pages 60–93)

      Robert C. Bast Jr., Blanche Simpson Bast and Herbert J. Rapp

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41692.x

    4. CRITICAL REVIEW OF PREVIOUSLY REPORTED CLINICAL TRIALS OF CANCER IMMUNOTHERAPY WITH NON-SPECIFIC IMMUNOSTIMULANTS (pages 94–123)

      Michael J. Mastrangelo, David Berd and Robert E. Bellet

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41693.x

    5. BACILLUS CALMETTE-GUÉRIN CONTACT IMMUNOTHERAPY OF LOCAL AND METASTATIC DEPOSITS OF RAT TUMORS (pages 124–134)

      R. W. Baldwin, D. G. Hopper and M. V. Pimm

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41694.x

    6. IMMUNOTHERAPY OF HUMAN SOLID TUMORS WITH BACILLUS CALMETTE-GUÉRIN: PROLONGATION OF DISEASE-FREE INTERVAL AND SURVIVAL IN MALIGNANT MELANOMA, BREAST, AND COLORECTAL CANCER (pages 135–159)

      Jordan U. Gutterman, Giora M. Mavligit, George Blumenshein, Michael A. Burgess, Charles M. McBride and Evan M. Hersh

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41695.x

    7. IMMUNOTHERAPY OF CANCER PATIENTS WITH BACILLUS CALMETTE-GUÉRIN: SUMMARY OF FOUR YEARS OF EXPERIENCE IN JAPAN (pages 160–186)

      Motomichi Torisu, Mitsuyuki Fukawa, Masaya Nishimura, Hiroaki Harasaki, Shoichi Kai and Jiro Tanaka

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41696.x

    8. RANDOMIZED TRIAL OF BACILLUS CALMETTE-GUÉRIN (PERCUTANEOUS ADMINISTRATION) AS SURGICAL ADJUVANT IMMUNOTHERAPY FOR PATIENTS WITH STAGE-II MELANOMA (pages 187–194)

      Carl M. Pinsky, Yashar Hirshaut, Harold J. Wanebo, Joseph G. Fortner, Valerie Miké, David Schottenfeld and Herbert F. Oettgen

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41697.x

    9. CHEMOIMMUNOTHERAPY OF SYNGENEIC MOUSE MAMMARY CARCINOMAS EMPLOYING METHANOL EXTRACTION RESIDUE (pages 195–208)

      Dan Cohen, Ilana Yron, N. B. Grover and David W. Weiss

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41698.x

    10. IMMUNOTHERAPY OF CANCER WITH CELL WALL SKELETON OF MYCOBACTERIUM BOVIS-BACILLUS CALMETTE-GUÉRIN: EXPERIMENTAL AND CLINICAL RESULTS (pages 209–227)

      Yuichi Yamamura, Ichiro Azuma, Tadayoshi Taniyama, Kazuhisa Sugimura, Fumio Hirao, Reiko Tokuzen, Midori Okabe, Waro Nakahara, Kousei Yasumoto and Mitsuo Ohta

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41699.x

    11. IMMUNOTHERAPY WITH NONVIABLE MICROBIAL COMPONENTS (pages 228–238)

      Edgar Ribi, Kelsey C. Milner, Donald L. Granger, Michael T. Kelly, Ken-ichi Yamamoto, Werner Brehmer, Reno Parker, Robert F. Smith and S. Michael Strain

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41700.x

    12. DISCUSSION PAPER: TREATMENT OF SUPERFICIAL BLADDER CANCER IN MAN (pages 239–240)

      David Eidinger and Alvaro Morales

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41701.x

    13. DESIGN OF PHASE-I TRIALS OF IMMUNOPOTENTIATORS FOR CANCER THERAPY: LEVAMISOLE AND CORYNEBACTERIUM PARVUM (pages 252–259)

      Yashar Hirshaut, Carl M. Pinsky, Harold J. Wanebo and Herbert F. Oettgen

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41703.x

    14. DOUBLE-BLIND LEVAMISOLE TRIAL IN RESECTABLE LUNG CANCER (pages 260–268)

      Willem K. Amery

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41704.x

    15. INFLUENCE OF POLY(A)·POLY(U) ON IMMUNE RESPONSE IN CANCER PATIENTS (pages 288–298)

      Harold J. Wanebo, Margaret Kemeny, Carl M. Pinsky, Yashar Hirshaut and Herbert F. Oettgen

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41706.x

    16. GENERAL DISCUSSION (pages 302–304)

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41708.x

  3. PART III. SPECIFIC ACTIVE IMMUNOTHERAPY (TUMOR VACCINES) FOR CANCER

    1. Top of page
    2. PART I. REPAIR AND REPLACEMENT OF INADEQUATE IMMUNE MECHANISMS
    3. PART II. NONSPECIFIC IMMUNOSTIMULATION AS THERAPY FOR CANCER
    4. PART III. SPECIFIC ACTIVE IMMUNOTHERAPY (TUMOR VACCINES) FOR CANCER
    5. PART IV. SPECIFIC ADOPTIVE IMMUNOTBERAPY FOR CANCER
    6. PART V. INSTRUCTIONAL METHODS OF IMMUNOTHERAPY
    7. PART VI. SPECISC IMMUNOTHERAPY (ANTIBODIES) FOR TREATMENT OF CANCER
    8. PART VII. CONFERENCE SUMMATION AND CRITIQUE
    1. TUMOR VACCINES FOR IMMUNOTHERAPY OF CANINE LYMPHOSARCOMA (pages 305–312)

      E. Benjamini, G. H. Theilen, M. Torten, S. Fong, S. Crow and A. M. Henness

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41709.x

    2. THERAPEUTIC EFFECTIVENESS OF NEURAMINIDASE-TREATED TUMOR CELLS AS AN IMMUNOGEN IN MAN AND EXPERIMENTAL ANIMALS WITH LEUKEMIA (pages 313–331)

      J. George Bekesi, Julia P. Roboz and James F. Holland

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41710.x

    3. ACTIVE SPECIFIC IMMUNOTHERAPY OF HUMAN SOLID TUMORS (pages 332–338)

      Francis E. Rosato, Elizabeth Miller, Ernest F. Rosato, Arthur Brown, Marc K. Wallack, Joan Johnson and Ann Moskowitz

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41711.x

    4. ADJUVANT IMMUNO- AND/OR CHEMOTHERAPY WITH NEURAMINIDASE-TREATED AUTOGENOUS TUMOR VACCINE AND BACILLUS CALMETTEGUÉRIN FOR HEAD AND NECK CANCERS (pages 339–344)

      Thomas J. Cunningham, Richard Antemann, Dominick Paonessa, Robert W. Sponzo and Deborah Steiner

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41712.x

    5. ADJUVANT IMMUNOTHERAPY IN BRONCHOGENIC CARCINOMA (pages 345–354)

      H. Takita, J. Minowada, T. Han, M. Takada and W. W. Lane

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41713.x

    6. IMMUNOTHERAPY OF HUMAN MALIGNANT MELANOMA WITH IRRADIATED TUMOR CELLS, ORAL BACILLUS CALMETTE-GUÉRIN, AND LEVAMISOLE (pages 355–366)

      Henry R. Shibata, L. Martin Jerry, Martin G. Lewis, Peter W. A. Mansell, Alena Capek and Grace Marquis

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41714.x

    7. IMMUNOTHERAPY OF CHRONIC MYELOCYTIC LEUKEMIA: EFFECTS OF DIFFERENT VACCINATION SCHEDULES (pages 367–383)

      Joseph E. Sokal, C. William Aungst, Michael Snyderman and German Gomez

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41715.x

    8. ACTIVE IMMUNIZATION OF CHILDREN SUFFERING FROM ACUTE LEUKEMIA IN REMISSION WITH “LIVING” MIXED LEUKOBLAST VACCINE AND MEANS OF ENHANCEMENT OF ANTILEUKEMIC IMMUNITY (pages 384–395)

      S. V. Skurkovich, N. S. Kisljak, T. I. Bulicheva, L. A. Makhonova, S. A. Majakova, A. S. Skorikova and E. I. Erjemkina

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41716.x

    9. IMMUNOTHERAPY OF OSTEOSARCOMA PATIENTS WITH VIRUS-MODIFIED TUMOR CELLS (pages 396–411)

      Alexander A. Green, Charles Pratt, Robert G. Webster and Kirby Smith

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41717.x

    10. IMMUNOGENICITY OF TUMORS ALKYLATED WITH CYCLOHEXYL-, BENZYL-, OR 2,4-DINITROPHENYLMETHACRYLATE (pages 412–427)

      William N. Palmer Jr., T. Leonard Swanson, George E. Moore and Paul M. Hyde

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41718.x

    11. IMMUNOCHEMOTHERAPY OF LUNG CANCER (pages 436–466)

      T. H. M. Stewart, Ariel C. Hollinshead, J. E. Harris, R. Belanger, A. Crepeau, G. D. Hooper, H. J. Sachs, D. J. Klaassen, W. Hirte, E. Rapp, A. F. Crook, M. Orizaga, D. P. S. Sengar and S. Raman

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41720.x

    12. DISCUSSION PAPER: EXPERIMENTAL AND CLINICAL IMMUNOPHARMACOLOGY DATA APPLICABLE TO CANCER IMMUNOTHERAPY (pages 467–484)

      G. Mathé, L. Schwarzenberg, O. Halle-Pannenko and M. C. Simmler

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41721.x

    13. GENERAL DISCUSSION (pages 485–491)

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41722.x

  4. PART IV. SPECIFIC ADOPTIVE IMMUNOTBERAPY FOR CANCER

    1. Top of page
    2. PART I. REPAIR AND REPLACEMENT OF INADEQUATE IMMUNE MECHANISMS
    3. PART II. NONSPECIFIC IMMUNOSTIMULATION AS THERAPY FOR CANCER
    4. PART III. SPECIFIC ACTIVE IMMUNOTHERAPY (TUMOR VACCINES) FOR CANCER
    5. PART IV. SPECIFIC ADOPTIVE IMMUNOTBERAPY FOR CANCER
    6. PART V. INSTRUCTIONAL METHODS OF IMMUNOTHERAPY
    7. PART VI. SPECISC IMMUNOTHERAPY (ANTIBODIES) FOR TREATMENT OF CANCER
    8. PART VII. CONFERENCE SUMMATION AND CRITIQUE
    1. ADOPTIVE CHEMOIMMUNOTHERAPY OF CANCER IN ANIMALS: A REVIEW OF RESULTS, PRINCIPLES, AND PROBLEMS (pages 492–504)

      Alexander Fefer, Albert B. Einstein Jr. and Martin A. Cheever

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41723.x

    2. SPECIFIC ADOPTIVE AND PASSIVE IMMUNOTHERAPY BY PARABIOSIS FOR SYNGENEIC MOUSE AND RAT TUMORS (pages 505–515)

      Chester M. Southam, Edward B. Bower, Violante E. Currie and Virginia I. Babcock

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41724.x

    3. COMPARISON OF ALLOGENEIC TUMOR VACCINE WITH LEUKOCYTE TRANSFER AND TRANSFER FACTOR TREATMENT OF HUMAN CANCER (pages 516–521)

      W. R. Jewell, J. H. Thomas, P. Morse and L. J. Humphrey

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41725.x

    4. ADOPTIVE TRANSFER AND SPECIFIC ACTIVE IMMUNIZATION OF PATIENTS WITH MALIGNANT MELANOMA (pages 522–532)

      H. F. Seigler, C. E. Buckley, L. B. Sheppard, B. J. Horne and W. W. Shingleton

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41726.x

    5. DISCUSSION PAPER: IN VITRO AUGMENTATION OF TUMOR IMMUNITY IN A MURINE METHYLCHOLANTHRENE SARCOMA SYSTEM (pages 533–540)

      Melvin A. Yarlott Jr. and Charles F. McKhann

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41727.x

    6. GENERAL DISCUSSION (pages 541–544)

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41728.x

  5. PART V. INSTRUCTIONAL METHODS OF IMMUNOTHERAPY

    1. Top of page
    2. PART I. REPAIR AND REPLACEMENT OF INADEQUATE IMMUNE MECHANISMS
    3. PART II. NONSPECIFIC IMMUNOSTIMULATION AS THERAPY FOR CANCER
    4. PART III. SPECIFIC ACTIVE IMMUNOTHERAPY (TUMOR VACCINES) FOR CANCER
    5. PART IV. SPECIFIC ADOPTIVE IMMUNOTBERAPY FOR CANCER
    6. PART V. INSTRUCTIONAL METHODS OF IMMUNOTHERAPY
    7. PART VI. SPECISC IMMUNOTHERAPY (ANTIBODIES) FOR TREATMENT OF CANCER
    8. PART VII. CONFERENCE SUMMATION AND CRITIQUE
    1. TRANSFER FACTOR VERSUS COMBINATION CHEMOTHERAPY: A PRELIMINARY REPORT OF A RANDOMIZED POSTSURGICAL ADJUVANT TREATMENT STUDY IN OSTEOGENIC SARCOMA (pages 558–574)

      John C. Ivins, Roy E. Ritts Jr., Douglas J. Pritchard, Gerald S. Gilchrist, Gerald C. Miller and William F. Taylor

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41730.x

    2. IMMUNOTHERAPY OF MURINE TUMORS WITH IMMUNE RNA (pages 575–591)

      Peter J. Deckers, Bosco S. Wang and John A. Mannick

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41731.x

    3. IMMUNOTHERAPY OF CANCER WITH IMMUNE RNA IN ANIMAL MODELS AND CANCER PATIENTS (pages 592–608)

      Yosef H. Pilch, Dieter Fritze, Jean B. de Kernion, Kenneth P. Ramming and David H. Kern

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41732.x

    4. IN VITRO AND IN VIVO STUDIES WITH THYMOSIN IN CANCER PATIENTS (pages 609–620)

      L. A. Schafer, A. L. Goldstein, J. U. Gutterman and E. M. Hersh

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41733.x

    5. DISCUSSION PAPER: TUMOR-SPECIFIC TRANSFER FACTOR THERAPY IN OSTEOGENIC SARCOMA: A TWO-YEAR STUDY (pages 621–627)

      V. S. Byers, A. S. Levin, L. LeCam, J. O. Johnston and A. J. Hackett

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41734.x

    6. GENERAL DISCUSSION (pages 628–633)

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41735.x

  6. PART VI. SPECISC IMMUNOTHERAPY (ANTIBODIES) FOR TREATMENT OF CANCER

    1. Top of page
    2. PART I. REPAIR AND REPLACEMENT OF INADEQUATE IMMUNE MECHANISMS
    3. PART II. NONSPECIFIC IMMUNOSTIMULATION AS THERAPY FOR CANCER
    4. PART III. SPECIFIC ACTIVE IMMUNOTHERAPY (TUMOR VACCINES) FOR CANCER
    5. PART IV. SPECIFIC ADOPTIVE IMMUNOTBERAPY FOR CANCER
    6. PART V. INSTRUCTIONAL METHODS OF IMMUNOTHERAPY
    7. PART VI. SPECISC IMMUNOTHERAPY (ANTIBODIES) FOR TREATMENT OF CANCER
    8. PART VII. CONFERENCE SUMMATION AND CRITIQUE
    1. SEROTHERAPY OF AVIAN RETICULOENDOTHELIOSIS VIRUS-INDUCED TUMORS (pages 634–646)

      Cheng-po Hu and T. Juhani Linna

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41736.x

    2. PREPARATION AND THERAPEUTIC POTENTIAL OF RABBIT ANTISERA WITH “DIRECTED” SPECIFICITIES FOR MOUSE LEUKEMIAS (pages 647–669)

      Arnold E. Reif, Cynthia M. Robinson and Peter J. Smith

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41737.x

    3. SPECIFIC CANCER THERAPY BY DRUGS ATTACHED TO TUMOR-SPECIFIC ANTIBODIES (page 670)

      D. A. L. Davies and G. J. O'Neill

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41738.x

    4. ANTIBODIES AS CARRIERS OF RADIONUCLIDES AND CYTOTOXIC DRUGS IN THE TREATMENT AND DIAGNOSIS OF CANCER (pages 671–689)

      T. Ghose, J. Tai, A. Guclu, S. T. Norvell, A. Bodurtha, J. Aquino and A. S. MacDonald

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41739.x

    5. DISCUSSION PAPER: HUMORAL IMMUNE RESPONSES TO TUMOR-ASSOCIATED ANTIGENS (pages 706–707)

      E. Frederick Wheelock

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41742.x

  7. PART VII. CONFERENCE SUMMATION AND CRITIQUE

    1. Top of page
    2. PART I. REPAIR AND REPLACEMENT OF INADEQUATE IMMUNE MECHANISMS
    3. PART II. NONSPECIFIC IMMUNOSTIMULATION AS THERAPY FOR CANCER
    4. PART III. SPECIFIC ACTIVE IMMUNOTHERAPY (TUMOR VACCINES) FOR CANCER
    5. PART IV. SPECIFIC ADOPTIVE IMMUNOTBERAPY FOR CANCER
    6. PART V. INSTRUCTIONAL METHODS OF IMMUNOTHERAPY
    7. PART VI. SPECISC IMMUNOTHERAPY (ANTIBODIES) FOR TREATMENT OF CANCER
    8. PART VII. CONFERENCE SUMMATION AND CRITIQUE
    1. IMMUNOTHERAPY OF CANCER IN MAN: CURRENT STATUS AND PROSPECTUS (pages 722–740)

      Stephen K. Carter

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41745.x

    2. CLOSING REMARKS (page 741)

      Chester M. Southam

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1976.tb41746.x

SEARCH

SEARCH BY CITATION